Skip to main content

Advertisement

Log in

Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet’s disease

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Behçet’s disease (BD) is a systemic vasculitis. Although its clinical characteristics are well defined, the etiology and immune pathogenesis are not clear yet. Neutrophilic vasculitis, which is a consequence of immunological events, is suggested as the underlying pathophysiological mechanism. Adenosine deaminase (ADA) is a non-specific marker of T-lymphocyte activation. A total of 75 patients with BD (45 women and 30 men) and 25 age-matched and gender-matched healthy control volunteers (13 women and 12 men) were included in this study. BD patients were divided into three groups according to their clinical findings: inactive BD patients (group 1, n=25); active BD patients under colchicine treatment (group 2, n=25); and active BD patients without colchicine treatment (group 3, n=25). Plasma ADA (p-ADA) levels of all BD patients and the control group were measured and compared. The relationship between p-ADA levels and disease activity, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels was evaluated and correlated. Patients with BD had significantly higher p-ADA levels (20.6±6.3 U/l) than control subjects (12.8±1.8 U/l; P<0.001). The p-ADA levels of patients with active BD were significantly (for each, P<0.05) higher than those of inactive BD patients or controls. On the other hand, the difference was not significant (P>0.05) between active patients with or without colchicine use. In addition, there were significantly positive correlations between p-ADA, ESR and CRP levels in patients with BD (for each, P<0.05). However, disease duration or haemoglobin levels were not relevant. ADA level may be a valuable and supportive indicator of disease activity and is not affected by colchicine therapy in BD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Behçet H (1937) Uber rezidivivierende Aphthose, durch ein Virus verursachte Geschwure am Mund, am Auge und an den Genitalien. Dermatol Wochenschr 105:1152–1157

    Google Scholar 

  2. Ghate JV, Jorizzo JL (1999) Behçet’s disease and complex aphthosis. J Am Acad Dermatol 40:1–18

    CAS  PubMed  Google Scholar 

  3. Evereklioglu C (2004) Managing the symptoms of Behçet’s disease. Expert Opin Pharmacother 5:317–328

    Article  CAS  PubMed  Google Scholar 

  4. Evereklioglu C, Yurekli M, Er H, Ozbek E, Hazneci E, Çekmen M (2000) Increased plasma adrenomedullin levels in patients with Behçet’s disease. Dermatology 201:312–315

    Article  CAS  PubMed  Google Scholar 

  5. Evereklioglu C, Inaloz HS, Kirtak N, Doganay S, Bulbul M, Ozerol E, Er H, Ozbek E (2002) Serum leptin concentration is increased in patients with Behçet’s syndrome and is correlated with disease activity. Br J Dermatol 147:331–336

    Article  CAS  PubMed  Google Scholar 

  6. Evereklioglu C, Er H, Turkoz Y, Cekmen M (2002) Serum levels of TNF-α, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm 11:87–93

    Article  CAS  PubMed  Google Scholar 

  7. Evereklioglu C, Turkoz Y, Er H, Inaloz HS, Ozbek E, Cekmen M (2002) Increased nitric oxide production in patients with Behçet’s disease: is it a new activity marker? J Am Acad Dermatol 46:50–54

    Article  PubMed  Google Scholar 

  8. Yazici H, Yurdakul S, Hamuryudan V (2001) Behçet’s disease. Curr Opin Rheumatol 13:18–22

    Article  CAS  PubMed  Google Scholar 

  9. Ungerer JPJ, Oosthnizen HM, Bissbort SH, Vermaak WJH (1992) Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem 38:1322–1326

    CAS  PubMed  Google Scholar 

  10. Al-Shammary FJ (1997) Adenosine deaminase activity in serum and pleural effusions of tuberculous and non-tuberculous patients. Biochem Mol Biol Int 43:763–769

    CAS  PubMed  Google Scholar 

  11. Sullivan J, Osborne WR, Wedgewood RJ (1977) Adenosine deaminase activity in lymphocytes. Br J Haematol 37:157–158

    CAS  PubMed  Google Scholar 

  12. Kose K, Yazici C, Ascıoglu O (2001) The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behçet’s disease. Clin Biochem 34:125–129

    Article  CAS  PubMed  Google Scholar 

  13. International Study Group for Behçet’s Disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 335:1078–1080

    PubMed  Google Scholar 

  14. Giusti G, Galanti B (1984) Colorimetric method. In: Bargmeyer HU (ed) Methods of enzymatic analysis. Verlag Chemie, Weinheim, pp 315–323

    Google Scholar 

  15. Evereklioglu C, Er H (2002) Increased corneal thickness in active Behçet’s disease. Eur J Ophthalmol 12:24–29

    CAS  PubMed  Google Scholar 

  16. Evereklioglu C, Cokkeser Y, Doganay S, Er H, Kizilay A (2001) Audio-vestibular evaluation in patients with Behçet’s syndrome. J Laryngol Otol 115:704–708

    Article  CAS  PubMed  Google Scholar 

  17. Gul A (2001) Behçet’s disease: an update on the pathogenesis. Clin Exp Rheumatol 19:6–12

    Google Scholar 

  18. Kastner DL (1997) Intermittent and periodic arthritic syndromes in arthritis and allied conditions, 13th edn. William J. Kopman Williams and Wilkins, Pennsylvania, USA, pp 1291–1297

    Google Scholar 

  19. Yamashita N, Kaneoka H, Kaneko S, Takeno M, Oneda K, Koizumi H, Kogure M, Inaba G, Sakane T (1997) Role of gamma delta T lymphocytes in the development of Behçet’s disease. Clin Exp Immunol 107:241–247

    Article  CAS  PubMed  Google Scholar 

  20. Baganha MF, Pego A, Maria A, Lima MA, Gaspar EV, Cordeiro AR (1990) Serum and pleural adenosine deaminase: correlation with lymphocytic populations. Chest 97:605–610

    CAS  PubMed  Google Scholar 

  21. Stancikova M, Lukac J, Istok R, Cristalli G, Rovensky J (1998) Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus. Clin Exp Rheumatol 16:583–586

    CAS  PubMed  Google Scholar 

  22. Hitoglou S, Hatzistilianou M, Gougoustamou D, Athanassiadou F, Kotsis A, Catriu D (2001) Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 20:411–416

    Article  CAS  PubMed  Google Scholar 

  23. Meunier P, Filipe P, Emerit I, Freitas J, Guerra Rodrigo F, Adenosine MC (1995) Deaminase in progressive systemic sclerosis. Acta Dermatol Venereol 75:297–299

    CAS  Google Scholar 

  24. Gener FA, Turkozkan N, Sever A (1998) The levels of adenosine deaminase activity in knee effusions. Turk J Biochem 13:97–101

    Google Scholar 

  25. Sari RA, Taysi S, Yilmaz O, Bakan N (2003) Correlation of serum levels of adenosine deaminase activity and its isoenzymes with disease activity in rheumatoid arthritis. Clin Exp Rheumatol 21:87–90

    CAS  PubMed  Google Scholar 

  26. Erkilic K, Evereklioglu C, Cekmen M, Ozkiris A, Duygulu F, Dogan H (2003) Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet’s disease: original contributions/clinical and laboratory investigations. Mediators Inflamm 12:107–116

    Article  PubMed  Google Scholar 

  27. Fukami R, Ohba S, Ishida K, Nakamura S, Konno M, Ohno S (1994) Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis. Nippon Ganka Gakkai Zasshi 98:287–292

    CAS  PubMed  Google Scholar 

  28. Mikulikova D, Lukac J, Ondrasik M (1989) The effect of colchicine and its derivatives on the activity of enzyme markers of T-lymphocytes. Cas Lek Cesk 128:1094–1097

    CAS  PubMed  Google Scholar 

  29. Evereklioglu C (2005) Current concepts in the etiology and treatment of Behçet’s disease. Surv Ophthalmol 6 (in press)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mustafa Calis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calis, M., Ates, F., Yazici, C. et al. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet’s disease. Rheumatol Int 25, 452–456 (2005). https://doi.org/10.1007/s00296-005-0612-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-005-0612-z

Keywords

Navigation